MD&DI

11/07/2025

Dexcom has issued a Class I recall for its G6 glucose sensor Android app due to a critical defect causing unexpected crashes. This issue could lead to missed glucose readings, alarms, and alerts—posing serious risks of hyperglycemic or hypoglycemic events.

To address the problem, Dexcom has retired older app versions, requiring users to update to version 1.15.0 immediately.

This recall follows other challenges Dexcom has faced this year, including user-reported issues with the G7 sensor and app malfunctions.

📲 Read the full story below.

Dexcom has issued a Class I recall for its G6 Android app due to crashes that could cause users to miss critical glucose alerts.

11/07/2025

As the medical device industry faces growing regulatory pressure and evolving sterilization challenges, ensuring biological safety and product sterility is more complex than ever.

In this Q&A, Nicole Cufaude and Dr. Egmont Semmler of TÜV SÜD offer insights into how manufacturers can future-proof their sterilization strategies, improve testing readiness, and navigate both novel and legacy sterilization pathways. https://utm.io/ujjRw

Learn the answers to 8 FAQs on novel sterilization pathways for medical device manufacturers — from testing to market — courtesy of TÜV SÜD America.

11/06/2025

Lisette Hilton's latest article in MD+DI reveals a critical shift in healthcare cybersecurity threats that every healthcare leader needs to understand. https://bit.ly/3LpG0Hw

Cybercriminals are pivoting from patient data theft to operational technology attacks.

Medical devices and hospital infrastructure are becoming prime targets, and traditional security measures aren't enough to protect against these sophisticated threats.

Why Asset Intelligence Matters: Asset intelligence provides comprehensive visibility into every connected device in your healthcare network - from MRI machines to infusion pumps. Without this visibility, you're essentially flying blind in an increasingly dangerous cyber landscape.

What cybersecurity measures is your organization implementing to protect critical medical devices?

Bad actors may be shifting from targeting patient records to attacking healthcare operational technology devices.

11/06/2025

Ritish Patnaik shares the fascinating origin story of Curve Biosciences' name in an exclusive interview clip with MD+DI.

The company, which recently secured $40 million in funding, is pioneering innovative blood testing technology for chronic disease monitoring.

Learn more about their groundbreaking work and recent funding milestone in the full article linked here: https://bit.ly/3JKTdds

11/04/2025

Trivia Tuesday: What medtech company found itself the target of several p**p jokes in 2021 after its co-founders were accused of fraud?

Find out below.

Trivia Tuesday: What medtech company found itself the target of several p**p joke headlines in 2021 after its co-founders were accused of fraud?

11/04/2025

Confluent Medical Technologies recently showcased its advanced capabilities at MD&M Trade Shows Midwest in Minneapolis, highlighting innovations such as Ultra Polyimide catheters, complex balloon catheters, titanium components, and biomedical textiles.

The company’s breakthrough Ultra Polyimide material delivers twice the strength of traditional polyimide while preserving internal tube space, enabling advanced delivery device designs without compromising critical functionality.

In this Show Short, Marketing Manager Brittany Mai provides insights into how Confluent’s Ultra Polyimide technology is transforming catheter design and performance. Check it out!

11/04/2025

Brand New Episode of Let's Talk Medtech!

Don't miss Lishan Aklog, MD on this brand new episode of Let's Talk Medtech!

As co-founder and CEO of PAVmed Inc. and Lucid Diagnostics, Dr. Aklog brings a unique perspective on what it takes to drive real innovation in healthcare.

Plus, he talks about the difficulties diagnostic companies face in finding funding. Listen now to discover how bold thinking translates into real-world impact in medical technology and diagnostics.

Lishan Aklog, MD, gives updates on PavMed and Lucid Diagnostics and shares why it’s difficult for diagnostic companies to obtain funding.

11/03/2025

Learn how AI and XR — extended reality — accelerate learning, adoption of new procedures, and adoption of surgical innovations in this insightful article from Paul Nendick, Clinical Technology and Product Officer at Fundamental XR. https://utm.io/ujjPD

Learn how AI and XR — extended reality — accelerate learning, adoption of new procedures, and adoption of surgical innovations.

10/31/2025

The Future of MedTech is AI-Native 🚀

Fascinating insights from EY's Arda Ural, MSc, MBA, PhD, and John Babitt on the latest episode of Let's Talk Medtech! They're discussing how artificial intelligence is completely transforming the medical technology landscape.

Key takeaway: We're not just talking about incremental improvements - this is about total redesign, rethinking, and reimagining processes from product design to company operations. The future belongs to AI-native thinkers.

Check out the full episode here: https://bit.ly/4huNogR

10/31/2025

At MD&M Trade Shows Midwest, I-PEX showcased its cutting-edge innovations in small, low-profile, high-density shielded cables and connectors, redefining the future of connectivity.

🎥 In the video, Senior Signal Integrity Field Applications Engineer Ro Richard dives into how these solutions are tailored for medical equipment, high-speed displays, Wi-Fi applications, and portable devices—ensuring unparalleled signal integrity and EMI protection.

💡 Discover how I-PEX is driving innovation in connectivity for the most demanding applications.

10/29/2025

Curve Biosciences just secured $40 million in funding to change chronic disease monitoring through its groundbreaking Whole-Body Intelligence platform.

We had the opportunity to speak with CEO and Co-founder Ritish Patnaik about what drives this innovative blood test technology and how it's set to transform healthcare.

His insights into the science behind detecting minute disease signals in blood are fascinating.

The funding round, led by Luma Group, will accelerate clinical validation and bring us closer to proactive, personalized chronic care that could change how we monitor diseases over decades.

Check out our conversation snippet below to hear directly from Ritish about the vision behind Curve's approach.

Link to MD+DI's full report on the funding in the link below. 👇
https://bit.ly/48NgTrQ

10/29/2025

Is ŌURA's latest funding round a sign that smart rings are about to revolutionize the wearables industry?

Seasoned journalist Lisette Hilton dives deep into this question, examining how ŌURA's innovative smart ring technology is challenging regulatory approaches in the wearables space.

The company's recent capital raise highlights growing investor confidence in smart ring technology as a viable alternative to traditional fitness trackers and smartwatches.

But beyond the financial implications, ŌURA's approach is causing regulators to take a hard look at the company's technology.

https://bit.ly/3WqVWM3

The smart ring manufacturer’s trajectory may be the secret sauce for thriving in an increasingly competitive consumer wearables market.